Clinical Factors that Predict POD24

Validation of POD24 as a robust early clinical end point of poor ...

Cox regression evaluated the association between POD24 as a time-dependent factor and subsequent overall survival (OS). A landmark analysis ...

Clinical factors predictive of POD24, a robust early ... - Lymphoma Hub

Follicular lymphoma (FL), the most common form of non-Hodgkin lymphoma and one that is generally associated with favorable outcomes, ...

Validation of POD24 as a robust early clinical end point of poor ...

Risk factors for POD24 included male sex, poor performance status, high-risk FLIPI score, and elevated β2-microglobulin. · We validated POD24 as ...

Validation of POD24 as a robust early clinical end point of poor ...

We performed a pooled analysis of 13 randomized clinical trials of patients with FL in the pre- and postrituximab eras to identify clinical factors that predict ...

Clinical Factors that Predict POD24, a Robust Early Clinical ...

Male sex, low-performance status, a high-risk FLIPI score, and increased 2-microglobulin were all risk factors for POD24. Read more!

Progression of disease within 24 months (POD24) in follicular ...

Progression of disease within 24 months of initial FL diagnosis (POD24) has emerged as a strong prognosticator in FL patients, associated with poorer outcomes.

Progression of disease within 24 months (POD24) in multiple ...

The research retrospectively analyzed the clinical data of MM patients and found that the occurrence of POD24 is an independent prognostic ...

Follicular Lymphoma: Refining Prognostic Models and Impact of Pod ...

Progression disease within 24 months (POD-24) has been described as a robust prognostic factor with high evidence to assess overall survival (OS), but it is ...

Evaluation of the Different Stratification Models for POD24 Prediction ...

Moreover, the mutation status of specific genes (including TP53, EZH2, TNFRSF14, and BCL2) has been reported to be relevant to early progression ...

Predicting early progression in follicular lymphoma - Liu

While well-established clinical risk factors allow to predict outcomes, risk ... An overview of the proportions of patients experiencing POD24 within clinical ...

Survival by First-line Treatment Type and Timing of Progression

However, the majority of reports on the impact of POD24 have been performed on patients from clinical trials or from single centers, and comprehensive real- ...

Progression of Disease Within 24 Months in Follicular Lymphoma Is ...

A pretherapy clinicogenetic risk model was specifically designed to sensitively predict POD24, termed the POD24 prognostic index (POD24-PI) ...

Evaluation of the Different Stratification Models for POD24 Prediction ...

Moreover, the mutation status of specific genes (including TP53, EZH2, TNFRSF14, and BCL2) has been reported to be relevant to early progression ...

Follicular Lymphoma: Refining Prognostic Models and Impact of Pod ...

Several models incorporating clinical laboratory variables and molecular biomarkers are able to predict its prognosis, allowing ... POD24 prediction in patients.

Early Relapse in First-Line Follicular Lymphoma: A Review of the ...

The POD24 prognostic index (POD24-PI) [33] is based on high-risk gene mutations, clinical risk factors (FLIPI > 2; i.e., high-risk FLIPI), and ...

Clinical features and outcomes of patients with follicular lymphoma

The FLIPI-2 showed the highest specificity of 73% to predict POD24, reflecting the prediction of correctly classifying as LR patients, but the ...

Paper: Development and Validation of a Machine-Learning Model to ...

3048 Development and Validation of a Machine-Learning Model to Predict POD24 Risk of Follicular Lymphoma. Program: Oral and Poster Abstracts

Risk factors for POD24 in patients with previously untreated follicular ...

Meta-analyses were performed in 31 studies with 11 factors. Results showed that elevated sIL-2R, β2m and LDH, total metabolic tumour volume > ...

Progression of disease within 2 years (POD24) is a clinically ...

Progression of disease within 2 years (POD24) is a clinically relevant endpoint to identify high-risk follicular lymphoma patients in real life.

Progression of Disease Within 24 Months (POD24) Based ... - OUCI

The POD24-based risk model had the highest sensitivity to predict to predict survival with the most satisfying AUC value for risk score (AUC = 0.869). In ...